Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effects of exendin-(9-39) on fasting blood
glucose and protein induced hypoglycemia on subjects with Congenital Hyperinsulinism. Funding
Source - FDA Office of Orphan Products Development (OODP).